Patents by Inventor Gustavo Barni

Gustavo Barni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110189319
    Abstract: Two very important factors in human life—which play vital roles in promoting well being—includes returning the body to homeostasis and giving boost to body called lifeforce to get overall health free from diseases, i.e., its optimal balanced functioning ability. When the body is at homeostasis, there is no place for disease. It is only when the body is out of balance (something is deficient, in excess or stagnating) that pain, illness or disease can occur. The application described is based on returning the body to homeostasis (removing the problem and balancing the body) by providing lifeforce and not on dealing with the symptom (e.g., pain, vitamin deficiency). Imbalance results in various diseases and adverse health conditions (starting from aging to diabetes and cancers). This wonderful composition will interact with the body in a way that allows it to boost lifeforce and reach homeostasis no matter which direction it was.
    Type: Application
    Filed: February 4, 2010
    Publication date: August 4, 2011
    Inventors: Lorn Leitman, Gustavo Barni
  • Publication number: 20080131532
    Abstract: Fast Asleep is an innovative new product with the latest and most effective delivery system. Fast Asleep comes in a dissolving strip very similar to Listerine®. An herbal composition for inducing sleep while simultaneously enhancing memory, Fast Asleep's oral strips contain a unique blend which provides hormone, natural herb and plant alkaloid. The blend consists of Kava-Kava extract (standardized to 30% kavalactones), Melatonin and Huperzine-A. The hormone and the sleep-inducing natural herb are in a range of 5% to 10% by weight of the composition and the memory-enhancing plant alkaloid is approximately 0.1% by weight of the composition.
    Type: Application
    Filed: September 12, 2007
    Publication date: June 5, 2008
    Inventors: Lorn Leitman, Gustavo Barni
  • Publication number: 20070027079
    Abstract: The products that exist on the market today that produce the same results are with injection. This new product, HGH Strips, is taken orally through strips that are placed on the back of the toungue. HGH Strips is scientifically developed with GHRP-2 (Growth Hormone Releasing Peptide-2), L-Lysine, L-Argenin and L-Valine which amino acids are specifics for increasing the natural production of GH (Growth Hormone) by the anterior pituitary deep inside the brain; also called Somatotropin, it influences in growth of cells, bones, muscles and organs throughout the body. HGH Strips helps to increasing the levels of IGF-1 (Insulin like Growth Factor-1 is a metabolite of human growth hormone) rise; a natural anabolic growth factor molecule. Studies have found that IGF-1 has increased lean body mass, reduced fat, built up bone and muscle tissue, it may even regenerate nerve tissues and boost the immune system.
    Type: Application
    Filed: July 27, 2005
    Publication date: February 1, 2007
    Inventors: Lorn Leitman, Gustavo Barni
  • Publication number: 20050090545
    Abstract: This invention with a new compound enables application of L-Arginine made with arginine alpha-ketoglutarate, arginine pyroglutamate, arginine ketoisocaproate and ornithine alpha-ketoglutarate to work together and separately along with other ingredients, topically. It is intended to improve the process by which these compounds work in the human organism. The invention is based on the facts that L-Arginine is: known to be the immediate precursor of the endogenous vasodilator substance found in the arterial blood vessels called “Endothelium-Derived Relaxing Factor” (EDRF) required for protein synthesis and, depending on the organism's needs, can either be metabolized to support glucose synthesis or catabolized to produce energy This simplified “noninvasive” application surpasses gastrointestinal digestion so the compounds will not degrade and favoring absorption into the circulatory system thus enhancing the compounds' effects and at much lower dosage levels than oral or parenteral administration.
    Type: Application
    Filed: October 22, 2003
    Publication date: April 28, 2005
    Inventors: Lorn Leitman, Gustavo Barni